Analystreport

Ovid Therapeutics Inc. (NASDAQ: OVID) had its price target raised by analysts at Citigroup Inc. from $2.40 to $2.50.

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com